Skip to main content

Medication leaflets

ATC
Veterinary

Română
English
Deutsch

Search for medicines for human use

Search for medicines for human use

Medication leaflets
Index of medicine substances
Letter I | page 2 | drug substances index

Index of medicine substances

Letter I · page 2

115

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Inactivated trivalent poliomyelitis vaccine

Indicated for: prevention of poliomyelitis

J07BF03 Antiinfectives for systemic use | Viral vaccines | Poliomyelitis vaccines
Inavolisib

Indicated for: breast cancer

L01EM06 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Phosphatidylinositol-3-kinase (PI3K) inhibitors
Inclisiran

Indicated for: dyslipidemia

C10AX16 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents
Indacaterol

Indicated for: chronic obstructive pulmonary disease

R03AC18 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
Indacaterol + glycopyronium

Indicated for: chronic obstructive pulmonary disease

R03AL04 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
Indacaterol + glycopyrronium bromide + mometasone

Indicated for: asthma

R03AL12 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
Indacaterol + mometasone

Indicated for: asthma

R03AK14 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
Indapamide

Indicated for: hypertension

C03BA11 Cardiovascular system | Low-ceiling diuretics, excluding thiazides | Sulfonamides, plain
Indapamide + amlodipine

Indicated for: hypertension

C08GA02 Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics
Indinavir

Indicated for: HIV-1 infection

J05AE02 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
Indocyanine green

Indicated for: diagnostic imaging

V04CX01 Various | Other diagnostic agents
Indomethacin

Indicated for: pain and inflammation

M01AB01 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances
Infliximab

Indicated for: inflammatory bowel disease

L04AB02 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors
Ingenoli mebutat

Indicated for: actinic keratosis

D06BX02 Dermatologicals | Chemotherapeutics for topical use | Other chemotherapeutics
Inosine

Indicated for: viral infections; immunomodulation

J05AX05 Antiinfectives for systemic use | Direct acting antivirals | Other antivirals
Inotersen

Indicated for: transthyretin amyloidosis

N07XX15 Nervous system | Other nervous system drugs | Other nervous system drugs
Inotuzumab ozogamycin

Indicated for: cancer

L01FB01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd22 (clusters of differentiation 22) inhibitors
Insulin aspart

Indicated for: diabetes mellitus

A10AB05 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, fast-acting
Insulin degludec

Indicated for: diabetes mellitus

A10AE06 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting
Insulin degludec + insulin aspart

Indicated for: diabetes mellitus

A10AD06 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
Insulin degludec + liraglutide

Indicated for: type 2 diabetes mellitus

A10AE56 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting
Insulin detemir

Indicated for: diabetes mellitus

A10AE05 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting
Insulin glargine

Indicated for: diabetes mellitus

A10AE04 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting
Insulin glargine + lixisenatide

Indicated for: type 2 diabetes mellitus

A10AE54 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, long-acting
Insulin glulisine

Indicated for: diabetes mellitus

A10AB06 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, fast-acting
Insulin lispro

Indicated for: diabetes mellitus

A10AD04 Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
Interferon alfa (HuIFN-alfa-Le)

Indicated for: viral infections; multiple sclerosis; cancer

L03AB01 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons
Interferon alfa 2A

Indicated for: viral infections; multiple sclerosis; cancer

L03AB04 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons
Interferon alfa 2B

Indicated for: viral infections; multiple sclerosis; cancer

L03AB05 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons
Interferon alfacon-1

Indicated for: viral infections; multiple sclerosis; cancer

L03AB09 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons

‹ Previous page

1
2
3
4

Copyright © prospecte.ro 2019-2026. All rights reserved.

We do not guarantee the accuracy, completeness, or timeliness of the displayed data.

The information on this site is for informational purposes only and does not replace the advice of a doctor or pharmacist.

For diagnosis, treatment, dosage, or side effects, consult your doctor, pharmacist, or the official leaflet.

Official sources

Sources:

CNAS
ANMDMR
EMA
ICBMV

About
Editorial policy
Methodology
Corrections
Contact